# Same-day Versus Rapid ART Initiation in HIV-positive Individuals Presenting With Symptoms of Tuberculosis

> **NCT05452616** · NA · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 610 (actual)

## Conditions studied

- Human Immunodeficiency Virus (HIV) Infection

## Interventions

- **OTHER:** ART first- Therapeutic use trial
- **OTHER:** TB results first- Therapeutic use trial

## Key facts

- **NCT ID:** NCT05452616
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-19
- **Primary completion:** 2024-11-26
- **Final completion:** 2025-01-14
- **Target enrollment:** 610 (ACTUAL)
- **Last updated:** 2025-04-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05452616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05452616, "Same-day Versus Rapid ART Initiation in HIV-positive Individuals Presenting With Symptoms of Tuberculosis". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05452616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*